Impact of Cytogenetics on Outcome after Allogeneic Transplantation for Myelodysplastic Syndrome or Post MDS Secundary Myeloid Leukemia. Leuk Res 2017. [DOI: 10.1016/s0145-2126(17)30379-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]

Hypoalbuminemia and hypergammaglobulinemia are associated with an increased infection risk in patients with myeloid malignancies treated with azacitidine. A 3-year monocentric retrospective study. Leuk Lymphoma 2015;57:1491-3. [PMID: 26430832 DOI: 10.3109/10428194.2015.1101096] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]

125 FEBRILE EPISODES IN PATIENTS WITH MDS TREATED WITH AZACITIDINE. A THREE YEAR MONOCENTRIC RETROSPECTIVE STUDY. Leuk Res 2015. [DOI: 10.1016/s0145-2126(15)30126-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]